A PRESCRIPTION FOR BETTER HEALTH
DEAD

Serial Number

90078184

Owner

CVS PHARMACY, INC.

Attorney

Erich G. Rhynhart

Filing Date

Jul 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

A PRESCRIPTION FOR BETTER HEALTH Trademark

Serial Number: 90078184

A PRESCRIPTION FOR BETTER HEALTH is a trademark filed by CVS PHARMACY, INC. on July 28, 2020. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

CVS PHARMACY, INC. (1,100 trademarks)

WOONSOCKET, RI 02895

Entity Type: 03

Trademark Details

Filing Date

July 28, 2020

Registration Date

Not Registered

Published for Opposition

April 13, 2021

Goods & Services

medical educational services, namely, providing courses of instruction in the medical fields of parenteral and enteral therapy and intraperitoneal therapy and treatment; medical education services, namely, training for medical professionals and patients regarding the use and application of enteral and parenteral therapy for medical purposes and distributing course materials in connection therewith; medical educational services, namely, providing individualized and group instruction, seminars and workshops for patients and caregivers of patients requiring parenteral and enteral therapy for medical purposes

pharmacy benefit management services; underwriting insurance for pre-paid health care; insurance and financial services pertaining to submission of medical claims, and handling of assignment of benefits, namely, medical insurance claims administrative services, administration of medical and pharmaceutical reimbursement collection for patients from private and public sources, administration of pharmaceutical reimbursement collection programs for others, administration of employee pharmaceutical benefits, administration of prepaid employee health care plans, financial counseling, and payment processing for medical services involving home and hospital care; claims processing of pharmaceutical insurance benefits, namely, processing and administering individual prescription claims history, benefit amounts, accumulations for deductibles and out-of-pocket expenses and expense summaries; insurance claims administration for medical claims and pharmaceuticals; processing of insurance claims and payment data; insurance services, namely verification of insurance benefit eligibility, insurance eligibility review and verification in the health industry

mail order of pharmaceuticals; pharmaceutical cost management for the health care benefit plans of others; health care utilization and review services as they relate to prescription drugs, namely, pharmaceutical cost management, drug review utilization services; business administrative services for medical referrals; doctor referrals; managed care services, namely, electronic processing of health care and pharmaceutical information; procurement, namely, purchasing pharmaceuticals for others; supplying prescription drugs to health plan participants for the funding organizations

therapeutic pharmaceutical services, namely, comprehensive health care programs comprising drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; medical services, namely, providing therapy management services relating to the provision of in-home and ambulatory infusion therapies and nutritional services; medical services, namely, infusion services provided at home and in clinics; nursing services; providing medical information concerning hemophilia; providing in-home and ambulatory dispensing and administering of infusion pharmaceuticals, and providing hemophilia, anti-infectives, pain remediation, palliative care, cardiac, inotropic, antitrypsin deficiency, pre-transplant, post-transplant, growth hormone, hepatitis, osteoarthritis, steroid, immune deficiency, rheumatoid arthritis, multiple sclerosis, interferon, alcohol dependency, oncology, fertility, vaccine and nutritional therapy services

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 15, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 15, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2023 EXRA
SOU EXTENSION 5 GRANTED
Nov 16, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 16, 2023 AITU
SOU EXTENSION 5 FILED
Nov 9, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 9, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 25, 2023 EXRA
SOU EXTENSION 4 GRANTED
May 23, 2023 EX4G
SOU EXTENSION 4 FILED
May 23, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
May 23, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2022 EXRA
SOU EXTENSION 3 GRANTED
Nov 16, 2022 EX3G
SOU EXTENSION 3 FILED
Nov 16, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 16, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2022 EXRA
SOU EXTENSION 2 GRANTED
May 18, 2022 EX2G
SOU EXTENSION 2 FILED
May 18, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
May 18, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2021 EXRA
SOU EXTENSION 1 GRANTED
Nov 29, 2021 EX1G
SOU EXTENSION 1 FILED
Nov 29, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 29, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 8, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 13, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 13, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 6, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 6, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2020 NWOS
NEW APPLICATION ENTERED
Jul 31, 2020 NWAP